Evidence map›Paper›PMID 42303897›Full record

ArticleEuropean journal of clinical pharmacology2026

Response to "Refining FIB-4-based risk stratification in adverse drug reactions".

Joana Henze, Lennard Goette, Harald Dormann, Carolin V Schneider, Corinna Meeßen, Anja Knüppel-Ruppert, Andrea Kriegisch-Stumpf, Matthias Schwab, Julia C Stingl, Katja S Just

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joana HenzeInstitute of Clinical Pharmacology, University Hospital RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany.
Lennard GoetteInstitute of Clinical Pharmacology, University Hospital RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany.
Harald DormannEmergency Department, Klinikum Fürth, Fürth, Germany.
Carolin V SchneiderDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Corinna MeeßenDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Anja Knüppel-RuppertEmergency Department, Klinikum Fürth, Fürth, Germany.
Andrea Kriegisch-StumpfCentral Emergency Department, Hospital Ingolstadt, Ingolstadt, Germany.
Matthias SchwabDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Julia C StinglDepartment of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Katja S JustInstitute of Clinical Pharmacology, University Hospital RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany. kjust@ukaachen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42303897
PMCPMC13272202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.